The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs
Open accessAbstract
Transcriptome analysis reveals a strong positive correlation between human Schlafen family member 11 (SLFN11) expression and the sensitivity of tumor cells to DNA-damaging agents (DDAs). Here, we show that SLFN11 preferentially inhibits translation of the serine/threonine kinases ATR and ATM upon DDA treatment based on distinct codon usage without disrupting early DNA damage response signaling. Type II transfer RNAs (tRNAs), which include all serine and leucine tRNAs, are cleaved in a SLFN11-dependent manner in response to DDAs. Messenger RNAs encoded by genes with high TTA (Leu) codon usage, such as ATR, display utmost susceptibility to translational suppression by SLFN11. Specific attenuation of tRNA-Leu-TAA sufficed to ablate ATR protein expression and restore the DDA sensitivity of SLFN11-deficient cells. Our study uncovered a novel mechanism of codon-specific translational inhibition via SLFN11-dependent tRNA cleavage in the DNA damage response and supports the notion that SLFN11-deficient tumor cells can be resensitized to DDAs by targeting ATR or tRNA-Leu-TAA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To functionally implicate SLFN11 in response to DNA-damaging chemotherapeutics (topoisomerase inhibitors, an anti-metabolite, and an alkylating agent), Li et al. demonstrated that genetic inhibition of SLFN11 expression caused chemoresistance [28].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Sharp, P. M., & Li, W.-H. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.3.1281 · Cited by 3,992
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Blackford, A. N., & Jackson, S. P. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.015 · Cited by 2,050
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes
Chan, P. P., & Lowe, T. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1309 · Cited by 1,078
GtRNAdb: a database of transfer RNA genes detected in genomic sequence
Chan, P. P., & Lowe, T. M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn787 · Cited by 867
The quantitative proteome of a human cell line
Beck, M., Schmidt, A., Malmstroem, J., Claassen, M., Ori, A., Szymborska, A., Herzog, F., Rinner, O., Ellenberg, J., & Aebersold, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.82 · Cited by 816
Targeting DNA Repair in Cancer: Beyond PARP Inhibitors
Brown, J. S., O’Carrigan, B., Jackson, S. P., & Yap, T. A. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0860 · Cited by 642
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Cheung-Ong, K., Giaever, G. N., & Nislow, C. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.04.007 · Cited by 608
Design of antisense oligonucleotides stabilized by locked nucleic acids
Kurreck, J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.1911 · Cited by 576
Cited by
Sorted by citations
Items 101–136 of 136
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC
Scattolin, D., Heijboer, F. W. J., Derks, J. L., von der Thüsen, J. H., Dumoulin, D. W., Speel, E. M., Guarneri, V., Pasello, G., & Dingemans, A. C. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104901 · Cited by 4
Proteostasis Deregulation by Metabolism Drives the Hallmarks of Cancer
Venkitaraman, A. R. (2026) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051424-052148 · Cited by 4
Velcrin compounds activate the SLFN12 tRNase to induce tomoptosis
Greulich, H. E. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.05.012 · Cited by 4
The regulation, function and disease relevance of cytoplasmic tRNAs
Stanley, R. E., Lowe, T. M., & Ignatova, Z. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-00963-3 · Cited by 5
Pommier, Y. G. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169841 · Cited by 4
Structural and functional characterization of human SLFN14
Luo, M., Jia, X., Wang, Z., Yang, J. Y., Wang, W., Chen, J., Ou, J.-Y., Feng, J.-X., Yu, B., Wang, S., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf484 · Cited by 4
SLFN11 Restricts LINE-1 Mobility
Ye, Z., Duan, Y., Zhang, A., Zhang, Z., Guo, S., Liu, Q., Yi, D., Wang, X., Zhao, J., Li, Q., et al. (2025) · Cells · doi:10.3390/cells14110790 · Cited by 2
Learning from nature: HIV elite controllers as blueprints for a functional cure
Kalidasan, V., & Das, K. T. (2025) · Virology Journal · doi:10.1186/s12985-025-03042-9 · Cited by 3
Al-Mesitef, S., Ando, D., Saigasaki, T., Sakaguchi, Y., Akagi, S., Mousa, A., Rashad, S., & Niizuma, K. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104038 · Cited by 2
Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AML
Small, S. H., Perez, R. E., Beauchamp, E. M., Baran, A. H., Willis, S. D., Fischietti, M., Schieber, M., Kocherginsky, M., Saleiro, D., & Platanias, L. C. (2024) · Blood Neoplasia · doi:10.1016/j.bneo.2024.100037 · Cited by 2
Bacterial Schlafens mediate anti-phage defensePreprint
Taboada, V. P., Wu, Y., Cassidy, R., Medvedev, K. E., Loeff, L., Nemudraia, A., & Nemudryi, A. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.24.666596 · Cited by 2
Ando, D., Rashad, S., & Niizuma, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188772 · Cited by 1
Shimauchi, T., Murai, J., Iwasaki, M., Phadungsaksawasdi, P., Ojima, T., Fujii, K., & Honda, T. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf037 · Cited by 1
tRNA modifications in viral replication
Pathirage, C., Koutmou, K. S., & Musier‐Forsyth, K. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111430 · Cited by 1
Lost in translation: interferon-stimulated genes targeting flavivirus protein synthesis
Cannac, M., Zoladek, J., & Nisole, S. (2026) · Journal of Virology · doi:10.1128/jvi.00303-26 · Cited by 1
Bąkowska-Żywicka, K., & Tyczewska, A. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf051 · Cited by 1
Recurrent Evolutionary Innovations in Rodent and Primate Schlafen Genes
Mordier, J., Fraisse, M., Cohen‐Tannoudji, M., & Molaro, A. (2025) · Genome Biology and Evolution · doi:10.1093/gbe/evaf172 · Cited by 3
Onji, H., Tate, S., Sakaue, T., Onishi, N., Matsumoto, T., Sugiyama, T., Higashiyama, S., & Murai, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.28.546820 · Cited by 1
Schlafen-11 and -9 are innate immune sensors for intracellular single-stranded DNAPreprint
Zhang, P., Hu, X., Li, Z., Liu, Q., Liu, L., Jin, Y., Liu, S., Zhao, X. H., Wang, J., Hao, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.24.581893 · Cited by 1
Self-citationSLFN11 puts the brakes on Alternative lengthening of telomeresPreprint
Khandagale, P., Welter, A. L., Huang, S.-Y. N., Taniyama, D., Machida, Y., & Pommier, Y. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.08.692725 · Cited by 1
C1orf109L promote R-loop accumulation induced DNA damage to inhibit cell growthPreprint
Dou, P., Li, Y., Xie, W., Xiao-qing, Z., Zhang, D., Ci, Y., Xiaohan, Z., Shupei, Q., Akhtar, M. L., Han, F., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/625749
Schlafen14 Regulates Gene Expression Depending on Codon UsagePreprint
Valenzuela, C., Saucedo, S., & Llano, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.19.533350
Dai, H., Yang, X., Sheng, X., Wang, Y., Zhang, S., Zhang, X., Hu, L.-P., Zhang, Z., Dong, X., Yin, W., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2723400/v1
Murai, Y., Jo, U., Murai, J., Jenkins, L. M. M., Huang, S.-Y. N., Chakka, S., Chen, L., Cheng, K., Fukuda, S., Takebe, N., et al. (2023) · doi:10.1158/0008-5472.c.6513573.v1
SLFN11 Induces Apoptosis Through Ribosome Biogenesis ImpairmentPreprint
Murai, J., Ogawa, A., Isoyama, S., Izumikawa, K., Masaru, M., Watanabe, S., Jo, U., Taniyama, D., Kitajima, S., Fujiwara, K., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4831222 · Cited by 1
Kim, J. H., Youn, Y., & Hwang, J. (2025) · Biocell · doi:10.32604/biocell.2025.062144
Ando, D., Rashad, S., & Niizuma, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.18.660468
EXOSC10-mediated pre-tRNA surveillance safeguards neuron survivalPreprint
Nishimoto, Y., Yang, X., & Gregory, R. I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.19.660564
Ding, C., Liu, X. A., Zhang, F., Uematsu, S., Qian, S., & Xiang, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.03.703619
Jo, U., Taniyama, D., Pegoraro, G., Wu, Y., Huang, S.-Y., Thomas, C. J., Ozbun, L., Tran, A. D., Saha, L., Murai, J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9297013/v1
Takahashi, M., & Nashimoto, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.12.718003
Ding, C., Liu, X. A., Zhang, F., Uematsu, S., Qian, S., & Xiang, Y. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003830
Tetramerization and RNA-guided filament assembly control Schlafen–Argonaute antiphage defensePreprint
Kuzmenko, A., Radford, K., Oguienko, A. D., Lisitskaya, L., Gelfenbein, D. M., Chou, T., Kulbachinskiy, A. V., & Aravin, A. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.29.728809
Wang, C., Zhu, M., Bao, L., Tcheuyap, V. T., Brugarolas, J., Luo, W., & Wang, Y. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03743-1
The dual role of Schlafen11 in brain tumors: Jekyll and Hyde
Natsumeda, M., Okada, M., Nakata, S., Takahashi, H., Kakinuma, C., Lucas, C. G., Watanabe, J., Tsukamoto, Y., Eberhart, C. G., Kakita, A., et al. (2026) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2026.2695215
Mouse Schlafen Family Proteins Control MHV68 Replication in Fibroblasts
González, S., Lundquist, A. N., & Tucker, J. M. (2026) · Pathogens · doi:10.3390/pathogens15111099
Metadata
- Authors
- Li, M., Kao, E., Malone, D., Gao, X., Wang, J. Y. J., & David, M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Li, Manqing
- David, Michael
- Venue
- Nature Structural & Molecular Biology
- Published
- 2018-10-29
- Volume
- 25
- Issue
- 11
- Pages
- 1047-1058
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- PMC
- PMC6579113
- OpenAlex
- W2895818115
- Cited by
- 136
- References
- 28
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 20 · 2023: 18 · 2022: 12 · 2021: 17 · 2020: 11 · 2019: 13
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM101982, R01GM128155)
- National Institute of Allergy and Infectious Diseases (R21AI088490, R21AI124199)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- SLFN11, DNA damage response, ATR kinase, ATM kinase, DNA-damaging agents, camptothecin, tumor cell sensitivity
- MeSH terms
- Camptothecin, Codon, DNA Damage, Humans, Nuclear Proteins, RNA, Transfer, RNA, Transfer, Leu, Protein Biosynthesis, Cell Death, RNA, Small Interfering, Cell Line, Tumor, HEK293 Cells, Topoisomerase I Inhibitors, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review